Contents

Clinical Cancer Drugs, Volume 1 - Number 2

Complex 3D Models to Study Drug Targeting of Invadopodia

, 1(2): 85 - 89

Njainday Pulo Jobe, Daniel Rosel, Ondrej Tolde, Jan Kosla and Jan Brabek


DOI: 10.2174/2212697X113016660003




Preclinical Models to Study Breast Cancer

, 1(2): 90 - 99

Cynthia M. Rodriguez, Paloma Valenzuela, Natzidielly Lerma and Giulio Francia


DOI: 10.2174/2212697X113026660005




The Preclinical Bases of the Rational Combination of Paclitaxel and Antiangiogenic Drugs

, 1(2): 100 - 115

Antonello Di Paolo, Guido Bocci and Romano Danesi


DOI: 10.2174/2212697X01666131218234741




Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy

, 1(2): 116 - 126

Annabelle Chow, Giulio Francia, Andrew Kouri, Christina Lee, John M. Ebos, Robert S. Kerbel and Urban Emmenegger


DOI: 10.2174/2212697X01666131218235200




Current Overview on the Usage of Poly(ADP-ribose)polymerase (PARP) Inhibitors in Treating Cancer

, 1(2): 127 - 148

Manikanta Swamy Murahari and Mayur C. Yergeri


DOI: 10.2174/2212697X01666140128002849




Acknowledgements to Reviewers

, 1(2): 149


DOI: 10.2174/2212697X0102140529153231




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science